Currently, little information exists on the calming and painkilling effects on animals using cannabidiol (CBD). Dr. Kimberly Guay, an Associate Professor at Tarleton State University in Stephenville, Texas, is hoping to change that by conducting research on the effects of CBD in horses and other livestock.
ISAAC /ADOBESTOCK.COM
Currently, little information exists on the calming and painkilling effects on animals using cannabidiol (CBD). Dr. Kimberly Guay, an Associate Professor at Tarleton State University in Stephenville, Texas, is hoping to change that by conducting research on the effects of CBD on horses and other livestock. Dr. Guay and her group hope that their future findings can benefit animals during transport and other times of stress. Here, Dr. Guay discusses her interest in this area, some of the current research, and her plans for the future.
What enticed you to research the effects of cannabidiol (CBD) on horses?
Dr. Kimberly Guay: My area of research details evaluating methods of monitoring and improving well-being in both companion animals, as well as livestock. Many of my students were already using CBD to help ease anxious behavior in their horses. CBD products for both horses and dogs have been available online for quite some time, so it seemed like a logical place to start.
Can you tell us more about the science behind your study (how were the horses selected, how frequently are they given treatment, what dose, how are the monitored, and so forth)?
Guay: We have multiple ongoing projects: An acute dose study-which is more controlled in that we use university horses, dose them once and monitor how quickly the CBD is detected in their system, as well as how long it took to metabolize it. Another single dose study we are performing measures a change of behavior (such as anxious or stereotypic behavior) after a single dose. We are researching several daily dose studies that will document any changes in behavior, immune response, and stress indices over time. Lastly, we will be doing several transport studies that will evaluate how CBD (both single and daily doses) may help mediate the stress of transport.
What form of CBD have you found to produce the best results?
Guay: Currently, it is too early to tell what methods deliver the best results.
How were the CBD products chosen?
Guay: Most CBD companies are very confident in their products, we have many who are eager to let us analyze their products.
Have you done quality control testing on the products?
Guay: Although it is evident that there are differences to products from different origins, we require the companies to send certificates of analysis for each batch of product that we use. Also, we only use one product in one project at a time so as not to confound the results.
Has the stigma around cannabis affected your work at all?
Guay: You mean aside from the jokes? Yes. Primarily, people are very interested and open to the potential of what CBD can offer, however some of my student workers have received hang-ups when we call looking for potential subject horses for studies.
What results has your research revealed so far?
Guay: Unfortunately, it is still too early to tell. We do anticipate releasing our initial findings in early 2021.
Do you think that CBD has the same effect on animals as it does on humans? Does that imply that animals also have an endocannabinoid system?
Guay: Most animals have an endocannabinoid system, where all of the receptors are still unknown. I expect much research to be seen in the near future that will verify and document similarities and unique differences of cannabinoid receptors in various species.
How will your research affect future CBD studies with animals?
Guay: Firstly, I hope to gain insight as to if, and how, cannabinoids and industrial hemp may be utilized to increase human and animal well-being. Then with my work, provide other researchers direction to focus on further studies.
What are the next steps in your CBD research? Do you plan to study any other cannabinoids as treatment options for animals?
Guay: Yes, we have multiple projects in the pipeline, but we are also planning to work with multiple species-not just horses. There is potential for work in transport and weaning stress in livestock species such as pigs and cattle. I am also very interested in the potential benefits of cannabinoids in wild-captive animals.
M. Colli, Cannabis Science and Technology3(4), 30-31 (2020).
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Empowering Women in Cannabis: Susan Audino, PhD, on Inclusivity, Integrity, and Industry Challenges
December 11th 2024Founder of S. A. Audino & Associates, LLC, Susan Audino, PhD, recently co-founded Saturn Scientific, LLC, a collaboration of five experienced individuals providing unbiased evaluations on the data and science for stakeholders in the cannabis industry. In this interview with Cannabis Science and Technology, Dr. Audino shares her unexpected path into analytical science and the cannabis industry as well as the obstacles she’s faced throughout her career. She highlights the gender bias she’s observed, such as unequal recognition of credentials and workplace challenges, while advocating for inclusivity and mentorship to empower women in science. Additionally, Dr. Audino recounts her experiences of navigating the male-dominated cannabis space, pushing for transparency, collaboration, and integrity in laboratory practices. Ultimately, Audino believes fostering mutual respect and knowledge-sharing is vital for the industry’s growth and resilience.
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
Gender Diversity and Innovation in the Cannabis Space: Insights from Tess Eidem, PhD
December 9th 2024Cannabis Science and Technology sat down with Tess Eidem, PhD, PCQI, member of Saturn Scientific, LLC, to discuss her journey from antibiotic research to cannabis microbiology and her observations throughout her career. Dr. Eidem highlights challenges women face in this male-dominated industry, including limited representation in leadership roles and frequent experiences of bias and discrimination. She emphasizes the importance of gender diversity in fostering innovation, improving product safety, and addressing women’s health needs in cannabis applications. Her advice to women scientists is to build strong professional relationships and carefully evaluate work environments to advance their careers in this evolving and often challenging space.